SNC Therapeutics, Inc.
PrivateLast Round
Seed
Mar 8, 2023
Total Funding Raised
$250,000
Company Overview
SNC Therapeutics, Inc. operates in Healthcare & Life Sciences and is based in Evanston, Illinois. Its latest recorded funding round was a Seed round in March 2023.
SNC Therapeutics, Inc. is a life sciences company that develops a synthetic nanocarrier platform for targeted drug and gene delivery to treat autoimmune and inflammatory diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SNC Therapeutics, Inc. Comparables
Compare SNC Therapeutics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Flashpoint Therapeutics | 88% | |
| Desna Therapeutics Inc. | 84% | |
| ImmunoVec | 83% |
For institutional investors. Book with your work email.
SNC Therapeutics, Inc. Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
SNC Therapeutics, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| AbbVie Ventures | Seed |
| General Inception | Seed |
| Portal Innovations | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 8, 2023
$250K round led by AbbVie Ventures.
For institutional investors. Book with your work email.
SNC Therapeutics, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about SNC Therapeutics, Inc.'s valuation, stock price, and market status.
Is SNC Therapeutics, Inc. a public or private company?
SNC Therapeutics, Inc. is a private company.
What is the current stock price of SNC Therapeutics, Inc.?
SNC Therapeutics, Inc. is a private company, so its shares have no public market price. Caplight tracks SNC Therapeutics, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is SNC Therapeutics, Inc. worth (valuation)?
Valuation information for SNC Therapeutics, Inc. is not publicly available.
Can I buy SNC Therapeutics, Inc. stock?
SNC Therapeutics, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was SNC Therapeutics, Inc.'s last funding round?
SNC Therapeutics, Inc.'s most recent funding round was Seed on March 8, 2023.
Who are the main investors in SNC Therapeutics, Inc.?
Key investors in SNC Therapeutics, Inc. include AbbVie Ventures.
Will SNC Therapeutics, Inc. IPO soon?
No public IPO plans have been announced for SNC Therapeutics, Inc..
How can I track SNC Therapeutics, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in SNC Therapeutics, Inc.'s shares on secondary markets.